Rebecca Luckett (Botswana)
Beth Israel Deaconess Medical Center Obstetrics & Gynecology
Moderator of 1 Session
Session Type
Public Health Oral Session
Session Time
08:45 - 09:45
[{"name":"EFFECTIVENESS OF ORGANISED PRIMARY HPV-BASED CERVICAL SCREENING OF WOMEN AGE 30-64: RANDOMISED HEALTHCARE POLICY \u003Csmall\u003E(ID 958)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":958,"presentation":"EFFECTIVENESS OF ORGANISED PRIMARY HPV-BASED CERVICAL SCREENING OF WOMEN AGE 30-64: RANDOMISED HEALTHCARE POLICY \u003Csmall\u003E(ID 958)\u003C\/small\u003E","session":"Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening","presenter":"Miriam Elfstr\u00f6m (Sweden)","photo":""},"playlist":[{"name":"EFFECTIVENESS OF ORGANISED PRIMARY HPV-BASED CERVICAL SCREENING OF WOMEN AGE 30-64: RANDOMISED HEALT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/GMT20200701-065616_Miriam-Elf_1920x1080-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/31\/GMT20200701-065616_Miriam-Elf_1920x1080-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/3190C5C5.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/GMT20200701-065616_Miriam-Elf_1920x1080-0.vtt"}]},{"name":"THE POSITIVE PREDICTIVE VALUE OF HPV TESTING VARIES WITH AGE AND REFLEX CYTOLOGY: FOLLOW-UP RESULTS FROM THE FIRST ROUND OF HPV PRIMARY SCREENING \u003Csmall\u003E(ID 721)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":721,"presentation":"THE POSITIVE PREDICTIVE VALUE OF HPV TESTING VARIES WITH AGE AND REFLEX CYTOLOGY: FOLLOW-UP RESULTS FROM THE FIRST ROUND OF HPV PRIMARY SCREENING \u003Csmall\u003E(ID 721)\u003C\/small\u003E","session":"Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening","presenter":"Dorothy Machalek (Australia)","photo":""},"playlist":[{"name":"THE POSITIVE PREDICTIVE VALUE OF HPV TESTING VARIES WITH AGE AND REFLEX CYTOLOGY: FOLLOW-UP RESULTS ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/721 Machalek .mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/31\/721 Machalek .mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/1D8E16A8.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/721 Machalek .vtt"}]},{"name":"IMPACT OF CERVICITIS ON PERFORMANCE OF PRIMARY HIGH RISK HPV TESTING FOLLOWED BY VISUAL EVALUATION IN WOMEN LIVING WITH HIV \u003Csmall\u003E(ID 573)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":573,"presentation":"IMPACT OF CERVICITIS ON PERFORMANCE OF PRIMARY HIGH RISK HPV TESTING FOLLOWED BY VISUAL EVALUATION IN WOMEN LIVING WITH HIV \u003Csmall\u003E(ID 573)\u003C\/small\u003E","session":"Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening","presenter":"Helena Painter (Botswana)","photo":""},"playlist":[{"name":"IMPACT OF CERVICITIS ON PERFORMANCE OF PRIMARY HIGH RISK HPV TESTING FOLLOWED BY VISUAL EVALUATION I","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/HELENA PAINTERS - IPVC Presentation 573.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/31\/HELENA PAINTERS - IPVC Presentation 573.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/2198CE1B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/HELENA PAINTERS - IPVC Presentation 573.vtt"}]},{"name":"PERFORMANCE COMPARISON AMONG CERVICAL, VAGINAL AND URINE SAMPLES IN CERVICAL CANCER SCREENING IN CHINA \u003Csmall\u003E(ID 876)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":876,"presentation":"PERFORMANCE COMPARISON AMONG CERVICAL, VAGINAL AND URINE SAMPLES IN CERVICAL CANCER SCREENING IN CHINA \u003Csmall\u003E(ID 876)\u003C\/small\u003E","session":"Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening","presenter":"Huifang Xu (China)","photo":""},"playlist":[{"name":"PERFORMANCE COMPARISON AMONG CERVICAL, VAGINAL AND URINE SAMPLES IN CERVICAL CANCER SCREENING IN CHI","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/IPVC20 - Hui Fang Xu - P876 - S800.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/31\/IPVC20 - Hui Fang Xu - P876 - S800.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/B45479A.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/IPVC20 - Hui Fang Xu - P876 - S800.vtt"}]},{"name":"DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS: A PILOT STUDY IN PERU \u003Csmall\u003E(ID 434)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":434,"presentation":"DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS: A PILOT STUDY IN PERU \u003Csmall\u003E(ID 434)\u003C\/small\u003E","session":"Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening","presenter":"Patti E. Gravitt (United States of America)","photo":""},"playlist":[{"name":"DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/Patti Gravitt - IPVC20 -PRESENTATION id 434 DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS A PILOT STUDY IN PERU.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/31\/Patti Gravitt - IPVC20 -PRESENTATION id 434 DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS A PILOT STUDY IN PERU.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/A4AE283B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/31\/Patti Gravitt - IPVC20 -PRESENTATION id 434 DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS A PILOT STUDY IN PERU.vtt"}]}]
{"type":2,"code":"9E32UU0x"}
[session]
[presentation]
[presenter]